A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

by Daniel H. Ahn, Kavya Krishna, Marlo Blazer, Joshua Reardon, Lai Wei, Christina Wu, Kristen K. Ciombor, Anne M. Noonan, Sameh Mikhail, Tanios Bekaii-Saab
Published 2017-02-01